|
|
| Machado,P.G.P.; Felipe,C.R.; Park,S.I.; Garcia,R.; Moreira,S.; Casarini,D.; Franco,M.; Alfieri,F.; Tedesco-Silva Jr.,H.; Medina-Pestana,J.O.. |
| The use of sirolimus (SRL) in combination with full doses of cyclosporin A (CsA) results in reduced one-year kidney allograft function, which is associated with shorter long-term allograft survival. We determined the effect of reduced CsA exposure on graft function in patients receiving SRL and prednisone. Ninety recipients of living kidney transplants receiving SRL (2 mg/day, po) were compared to 35 recipients receiving azathioprine (AZA, 2 mg kg-1 day-1, po). All patients also received CsA (8-10 mg kg-1 day-1, po) and prednisone (0.5 mg kg-1 day-1). Efficacy end-point was a composite of biopsy-confirmed acute rejection, graft loss, or death at one year. Graft function was measured by creatinine, creatinine clearance, and graft function deterioration... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: Sirolimus; Cyclosporine; Graft function; Immunosuppression; Kidney transplantation. |
| Ano: 2004 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000900004 |
| |
